Cover Image
市場調查報告書

美國的顯影劑、放射性醫藥品市場

Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2016

出版商 Decision Resources Group - Medtech Solutions 商品編碼 140085
出版日期 內容資訊 英文 67 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的顯影劑、放射性醫藥品市場 Contrast Agents and Radiopharmaceuticals | Market Analysis | US | 2016
出版日期: 2016年09月30日 內容資訊: 英文 67 Pages
簡介

美國的顯影劑、放射性醫藥品市場預計由於在CEUS(造影超音波) 及PET檢驗診斷中顯影劑的使用擴大而促進成長。然而,該市場根據模式的不同由於釓及放射線的暴露對健康產生影響這樣的不穩定要素,將限制幾分成長。還有轉移到價值為基礎的照護(患者的偏好、價值觀為基礎的醫療),支撐利用最精密鮮明的影像的診斷方法,另一方面也會妨礙其利用。

本報告提供美國的顯影劑及放射性醫藥品整體市場,及各分類市場概要與分析,競爭分析等。

摘要整理

履歷

第1章 顯影劑及放射性醫藥品市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 市場趨勢
  • 競爭概要
  • 競爭情形
  • 市場佔有率
  • 市場要素與發展

第2章 放射性醫藥品市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 市場趨勢
  • 競爭概要
  • 市場佔有率

第3章 CT及X光掃描顯影劑市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 市場趨勢
  • 競爭概要
  • 市場佔有率

第4章 MRI顯影劑市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 市場趨勢
  • 競爭概要
  • 市場佔有率

第5章 超音波顯影劑市場

  • 市場概要
  • 市場定義
  • 市場預測資料
  • 市場趨勢
  • 競爭概要
  • 市場佔有率

附錄:分析方法

附錄:簡稱、詞彙表

附錄:參考文獻

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: M360RP0007

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by uncertainty surrounding the health impacts of gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.

Questions Answered in This Report:

The FDA recently expanded approval for the use of CEUS in radiology procedures.

  • What procedures does this approval extend to? What additional procedures could be approved in the future?
  • Which contrast agents received FDA approval?
  • How will competitors that do not have FDA approval react?

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

  • How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
  • What are the key differences between linear and macrocylic GBCAs and how will market demand for these products shift over the forecast period?
  • Will other imaging modalities cannibalize contrast-enhanced MRI procedures?

While less concerning than in the past, radiation dose concerns still exert a limiting effect on procedure volumes for some imaging modalities.

  • How are US radiologists responding and what methods are they using to ensure image quality?
  • Which procedures are being cannibalized by other modalities that do not require radiation for image acquisition?

The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the effects of the Chalk River nuclear reactor decommission.

  • What are nuclear pharmacies doing to ensure a steady supply of technetium? How are GPOs and hospitals responding?
  • What other major legislative factors will further complicate the supply of technetium over the forecast period?
  • How is this impacting the transition away from HEU to LEU nuclear reactors?
  • How will this impact ASPs in the US market?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1 Contrast Agent and Radiopharmaceutical Market

  • 1.1 Market Highlights
  • 1.2 Market Definitions
  • 1.3 Market Forecast Data
  • 1.4 General Market Trends
  • 1.5 Competitive Highlights
  • 1.6 Competitive Landscape
  • 1.7 Market Shares
  • 1.8 Market Factors and Developments

2 Radiopharmaceutical Market

  • 2.1 Market Highlights
  • 2.2 Market Definitions
  • 2.3 Market Forecast Data
  • 2.4 General Market Trends
  • 2.5 Competitive Highlights
  • 2.6 Market Shares

3 CT and X-Ray Contrast Agent Market

  • 3.1 Market Highlights
  • 3.2 Market Definitions
  • 3.3 Market Forecast Data
  • 3.4 General Market Trends
  • 3.5 Competitive Highlights
  • 3.6 Market Shares

4 MRI Contrast Agent Market

  • 4.1 Market Highlights
  • 4.2 Market Definitions
  • 4.3 Market Forecast Data
  • 4.4 General Market Trends
  • 4.5 Competitive Highlights
  • 4.6 Market Shares

5 Ultrasound Contrast Agent Market

  • 5.1 Market Highlights
  • 5.2 Market Definitions
  • 5.3 Market Forecast Data
  • 5.4 General Market Trends
  • 5.5 Competitive Highlights
  • 5.6 Market Shares

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2014-2024
  • Table 1: Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2015 and 2024
  • Table 2: Contrast Agent and Radiopharmaceutical Market Leaders, by Product Type and Revenue, US, 2015
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Table 5: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 6: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Table 7: Key Report Updates
  • Table 8: Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
  • Table 9: Version History
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2014-2024
  • Table 10: Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2014-2024
  • Table 11: Contrast Agent and Radiopharmaceutical Market Growth, by Product Type, US, 2015-2024
  • Figure 3: Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2015
  • Table 12: Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2015
  • Table 13: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Table 14: Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Table 15: Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Figure 4: Radiopharmaceutical Market, by Product Type, US (USD), 2014-2024
  • Table 16: Radiopharmaceutical Market, by Product Type, US (USD), 2014-2024
  • Table 17: Radiopharmaceutical Market Growth, by Product Type, US, 2015-2024
  • Table 18: Nuclear Medicine System Installed Base, by Product Type, US, 2014-2024
  • Figure 5: Radiopharmaceutical Revenue Market Shares, US, 2015
  • Table 19: Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2015
  • Figure 6: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2014-2024
  • Table 20: CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2014-2024
  • Table 21: CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2015-2024
  • Table 22: CT Device Market, by Procedure Type, US (USD), 2014-2024
  • Table 23: CT Device Market Growth, by Procedure Type, US , 2015-2024
  • Table 24: CT and X-Ray System Installed Base, by Product Type, US, 2014-2024
  • Figure 7: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2015
  • Table 25: CT and X-Ray Contrast Agent Revenue Market Shares, US, 2015
  • Figure 8: MRI Contrast Agent Market, by Procedure Type, US (USD), 2014-2024
  • Table 26: MRI Contrast Agent Market, by Procedure Type, US (USD), 2014-2024
  • Table 27: MRI Contrast Agent Market Growth, by Procedure Type, US, 2015-2024
  • Table 28: MRI System Installed Base, by Procedure Type, US, 2014-2024
  • Figure 9: MRI Contrast Agent Revenue Market Shares, US, 2015
  • Table 29: MRI Contrast Agent Revenue Market Shares, US, 2015
  • Figure 10: Ultrasound Contrast Agent Market, US (USD), 2014-2024
  • Table 30: Ultrasound Contrast Agent Market, US (USD), 2014-2024
  • Figure 11: Ultrasound Contrast Agent Revenue Market Shares, US, 2015
  • Table 31: Ultrasound Contrast Agent Revenue Market Shares, US, 2015
  • Table 32: Acronyms and Initialisms
Back to Top